Sifting through countless of stocks in the Health Care Equipment & Supplies industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in GE HealthCare Technologies Inc. or Baxter International Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how GE HealthCare Technologies Inc. and Baxter International Inc. compare based on key financial metrics to determine which better meets your investment needs.

About GE HealthCare Technologies Inc. and Baxter International Inc.

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women’s health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women’s health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors’ offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Latest Health Care Equipment & Supplies and GE HealthCare Technologies Inc., Baxter International Inc. Stock News

As of June 18, 2026, GE HealthCare Technologies Inc. had a $28.0 billion market capitalization, compared to the Health Care Equipment & Supplies median of $350.0 million. GE HealthCare Technologies Inc.’s stock is down 24.9% in 2026, down 4.5% in the previous five trading days and down 13.42% in the past year.

Currently, GE HealthCare Technologies Inc.’s price-earnings ratio is 14.8. GE HealthCare Technologies Inc.’s trailing 12-month revenue is $21.0 billion with a 9.1% net profit margin. Year-over-year quarterly sales growth most recently was 7.4%. Analysts expect adjusted earnings to reach $4.873 per share for the current fiscal year. GE HealthCare Technologies Inc. currently has a 0.2% dividend yield.

As of June 18, 2026, Baxter International Inc. had a $10.3 billion market cap, putting it in the 78th percentile of all stocks. Baxter International Inc.’s stock is up 4.1% in 2026, down 2.9% in the previous five trading days and down 33.52% in the past year.

Currently, Baxter International Inc. does not have a price-earnings ratio. Baxter International Inc.’s trailing 12-month revenue is $11.3 billion with a -9.7% net profit margin. Year-over-year quarterly sales growth most recently was 2.9%. Analysts expect adjusted earnings to reach $1.916 per share for the current fiscal year. Baxter International Inc. currently has a 0.2% dividend yield.

How We Compare GE HealthCare Technologies Inc. and Baxter International Inc. Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at GE HealthCare Technologies Inc. and Baxter International Inc.’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

GE HealthCare Technologies Inc. and Baxter International Inc.’s Quality Grades

Company	Ticker	Quality
GE HealthCare Technologies Inc.	GEHC	B
Baxter International Inc.	BAX	B

Like the Value Grade, AAII’s A+ Investor Quality Grade comes from the percentile rank of key metrics. Specifically, the Quality Score is the percentile rank of the average of the percentile ranks of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and the F-Score.

The score is variable, meaning it can consider all eight measures or, should any of the eight measures not be valid, the remaining measures that are valid. To be assigned a Quality Score, stocks must have a valid (non-null) measure and corresponding ranking for at least four of the eight quality measures.

The Quality Score is used to assess the underlying “quality” of a particular stock. A higher-quality stock possesses traits associated with upside potential and reduced downside risk. Backtesting of the Quality Grade shows that stocks with higher grades, on average, outperformed stocks with lower grades over the period of 1998 through 2019.

Stocks receive better grades (higher scores) for having higher scores for the quality subcomponents and worse grades (lower scores) for lower scores for the subcomponents.

GE HealthCare Technologies Inc. has a Quality Score of 66, which is Strong. Baxter International Inc. has a Quality Score of 62, which is Strong.

The Quality Grade Winner: It’s a Tie!

Looking at the Quality Grade breakdown above, both GE HealthCare Technologies Inc. and Baxter International Inc. have a grade of B. For investors who focus solely on a company’s overall quality, you will need to conduct further research into both companies to see if they are a good fit for your portfolio. As a good rule of thumb, you should always analyze multiple factors based on a wide range of metrics before choosing a company to invest in.

GE HealthCare Technologies Inc. and Baxter International Inc.’s Momentum Grades

Company	Ticker	Momentum
GE HealthCare Technologies Inc.	GEHC	D
Baxter International Inc.	BAX	D

Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.

Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.

GE HealthCare Technologies Inc. has a Momentum Score of 23, which is Weak. Baxter International Inc. has a Momentum Score of 28, which is Weak.

The Momentum Stock Winner: No Clear Winner

Neither GE HealthCare Technologies Inc. or Baxter International Inc. has a strong enough Momentum Grade to be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if GE HealthCare Technologies Inc. or Baxter International Inc. is the better investment when it comes to momentum.

GE HealthCare Technologies Inc. and Baxter International Inc.’s Estimate Revisions Grades

Company	Ticker	Earnings Estimate
GE HealthCare Technologies Inc.	GEHC	D
Baxter International Inc.	BAX	D

Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.

GE HealthCare Technologies Inc. has a Earnings Estimate Score of 24, which is Negative. Baxter International Inc. has a Earnings Estimate Score of 34, which is Negative.

The Earnings Estimate Revisions Stock Winner: No Clear Winner

Neither GE HealthCare Technologies Inc. or Baxter International Inc. has an Earnings Estimate Revisions Grade that could be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if GE HealthCare Technologies Inc. or Baxter International Inc. is the better investment when it comes to estimate revisions.

Other GE HealthCare Technologies Inc. and Baxter International Inc. Grades

In addition to Quality, Momentum and Estimate Revisions, A+ Investor also provides grades for Value and Growth.

Growth investing builds on the idea that stocks of companies exhibiting strong, consistent and prolonged growth outperform those of slower-growth companies. AAII measures growth through consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations.

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection. Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether GE HealthCare Technologies Inc. and Baxter International Inc. pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, GE HealthCare Technologies Inc. or Baxter International Inc. Stock?

Overall, GE HealthCare Technologies Inc. stock has a Momentum Score of 23, Estimate Revisions Score of 24 and Quality Score of 66.

Baxter International Inc. stock has a Momentum Score of 28, Estimate Revisions Score of 34 and Quality Score of 62.

Comparing GE HealthCare Technologies Inc. and Baxter International Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.